An investigation was completed at the manufacturing site in the (b)(4).Based on the dhr reviewed, this lot had (b)(4) pieces and it was manufactured on 7/16/2015.No defects were reported during processing, packaging or final inspection.The investigation revealed that this problem was not due to an assembly, material, or process issues.No defective product has been returned to manufacturer for evaluation.Since no device was returned for analysis the root cause for the event has not been determined.
|
On (b)(6) 2015- end user (physician) has reported medwatch (b)(4) to the fda and stated that during the procedure for the right breast lumpectomy, the end user found contamination (blood) inside the probe cover during the procedure.End user checked very carefully and found a small hole at the seam of cover.A small hole could have been present prior to use or could been a weak spot that opened with use.On the same day that the end user reported this to medwatch, there were complaints of two instances of gross contamination from the neoprobe handle and possibly effected sterility.There was no patient injury report of additional treatment.Product number pc1419, lot number reported was d151951.
|